Envista Holdings Corporation
envistaco.comWhat Do They Do?
Makes dental implants and orthodontic products, including aligners and related software, for dental specialists and other dental professionals; also sells dental imaging equipment and general dental supplies to dental offices, clinics, and hospitals.
10-K for FY2025, filed Feb 12, 2026Our Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative…View ↗
We are a world leader in the field of innovative Dental Implant Solutions, offering a full portfolio of solutions that enable dentists to…View ↗
For over 60 years, our Orthodontic Solutions businesses have provided orthodontic professionals with high quality, innovative products…View ↗
Our Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices…View ↗
Our Diagnostic Solutions business is focused on dental imaging, X-ray, and intraoral scanner solutions used in dental offices, clinics and…View ↗
Our Consumables Solutions business markets a broad offering of general dental products that are used in dental offices, clinics and…View ↗
How Do They Make Money?
Customers generally pay for dental equipment, consumables, and spare parts when products ship. They pay over the term of extended warranties and service arrangements; the company may also receive cash in advance.
10-K for FY2025, filed Feb 12, 2026
-
10-K for FY2025, filed Feb 12, 2026
FY2025 revenue by reportable segment ↗
$2.7B
-
10-K for FY2025, filed Feb 12, 2026
$2.7B ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Specialty Products & Technologies
Mix
10-K for FY2025, filed Feb 12, 2026 |
64%
FY2022: 62%
|
Specialty Products & Technologies, FY2025
$1.8B Sources
|
Mix |
|
Equipment & Consumables
Mix
10-K for FY2025, filed Feb 12, 2026 |
36%
FY2022: 38%
|
Equipment & Consumables, FY2025
$966.7M Sources
|
Mix |
Who Are Their Customers?
Dental specialists, general dentists, dental laboratories, and dental service organizations buy the company’s products. Specialty products are typically sold directly to end users, while Equipment & Consumables products mainly go through channel partners; third-party distributors also distribute products.
10-K for FY2025, filed Feb 12, 2026Our Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative…View ↗
Our Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices…View ↗
Typical customers and end-users of our products include dental specialists such as orthodontists, periodontists, implantologists and…View ↗
In 2025, we distributed approximately 42% of our products through third-party distributors. One customer, Henry Schein, Inc. (“Henry…View ↗
10-K for FY2025, filed Feb 12, 2026
Sales to the Company’s largest customer were 12% of total sales for the year ended December 31, 2025 and 10% for the years ended December…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 2 cents of every revenue dollar as net income in FY2025 and turned 8 cents into free cash flow.
10-K for FY2025, filed Feb 12, 2026
$216.1MView ↗
10-K for FY2025, filed Feb 12, 2026
$47MView ↗
10-K for FY2025, filed Feb 12, 2026
$230.4MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 5, 2026
$53.7MView ↗
- ▲ +103%
- vs $26.4M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 5, 2026
Open tableView ↗
-
Aug 19, 2026
CEO Paul Keel became board chair
Paul Keel was appointed Chair of the Board, succeeding Scott Huennekens, who remains a director and Lead Independent Director.
Sources
8-K, filed Aug 19, 2026
On August 17, 2026, upon the recommendation of the Nominating and Governance Committee of the Board, the Board appointed Paul Keel, the…View ↗
-
Aug 5, 2026
Raised full-year 2026 outlook
The company raised its core sales growth, adjusted EBITDA growth, and adjusted diluted earnings per share guidance.
Sources
8-K, filed Aug 5, 2026
We are updating our guidance for the full year 2026:View ↗
Growing. Revenue grew 8% in 4 years, from $2.5B in FY2021 to $2.7B in FY2025, about 2% a year.
Loading...
